AR094413A1 - Composiciones nutricionales conteniendo un componente neurológico y usos de las mismas - Google Patents

Composiciones nutricionales conteniendo un componente neurológico y usos de las mismas

Info

Publication number
AR094413A1
AR094413A1 ARP140100093A ARP140100093A AR094413A1 AR 094413 A1 AR094413 A1 AR 094413A1 AR P140100093 A ARP140100093 A AR P140100093A AR P140100093 A ARP140100093 A AR P140100093A AR 094413 A1 AR094413 A1 AR 094413A1
Authority
AR
Argentina
Prior art keywords
nutritional compositions
neurological component
neurological
same
compositions containing
Prior art date
Application number
ARP140100093A
Other languages
English (en)
Inventor
Kuang Chenzhong
Xiao Yan
K Poels Eduard
Jouni Zeina
Hondmann Dirk
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of AR094413A1 publication Critical patent/AR094413A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid

Abstract

La presente divulgación se refiere a composiciones nutricionales que comprenden un componente neurológico, en donde, el componente neurológico puede promover el desarrollo del sistema nervioso y el cerebro y además puede proporcionar reparación y protección neurológica; el componente neurológico puede incluir fosfatidil-etanolamina, esfingomielina, citidina difosfato-colina, ceramida, uridina, por lo menos un gangliósido, y mezcla de los mismos; la divulgación además se refiere a métodos para promover la salud del sistema nervioso y el cerebro al proveer dichas composiciones nutricionales a sujetos destinatarios, que incluyen a pacientes pediátricos.
ARP140100093A 2013-01-11 2014-01-10 Composiciones nutricionales conteniendo un componente neurológico y usos de las mismas AR094413A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/739,787 US20140199265A1 (en) 2013-01-11 2013-01-11 Nutritional compositions containing a neurologic component and uses thereof

Publications (1)

Publication Number Publication Date
AR094413A1 true AR094413A1 (es) 2015-07-29

Family

ID=49887324

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140100093A AR094413A1 (es) 2013-01-11 2014-01-10 Composiciones nutricionales conteniendo un componente neurológico y usos de las mismas

Country Status (16)

Country Link
US (1) US20140199265A1 (es)
EP (1) EP2943079A1 (es)
CN (1) CN104883909A (es)
AR (1) AR094413A1 (es)
AU (1) AU2013372898B2 (es)
BR (1) BR112015016358A2 (es)
CA (1) CA2912246A1 (es)
HK (1) HK1214090A1 (es)
IN (1) IN2015DN04207A (es)
MX (1) MX2015008585A (es)
PE (1) PE20151771A1 (es)
PH (1) PH12015501504A1 (es)
RU (1) RU2015120263A (es)
SG (1) SG11201503682VA (es)
TW (1) TW201440669A (es)
WO (1) WO2014109862A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10455854B2 (en) 2013-03-11 2019-10-29 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9980506B2 (en) 2013-03-11 2018-05-29 Mead Johnson Nutrition Co. Nutritional compositions containing structured fat globules and uses thereof
US9661874B2 (en) 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9241923B2 (en) 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US9226914B2 (en) 2013-07-16 2016-01-05 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US10028519B2 (en) * 2014-03-05 2018-07-24 Mead Johnson Nutrition Company Nutritional compositions containing ceramide and uses thereof
US20150305359A1 (en) * 2014-04-24 2015-10-29 Mead Johnson Nutrition Company Nutritional compositions directed to subjects having cow's milk protein allergies
US20160095339A1 (en) * 2014-10-01 2016-04-07 Mead Johnson Nutrition Company Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
CN106998774A (zh) * 2014-11-26 2017-08-01 雅培制药有限公司 包含人乳低聚糖、多不饱和脂肪酸、核苷酸以及叶黄素的婴儿配方
US10617701B2 (en) 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US20170006897A1 (en) * 2015-07-10 2017-01-12 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
EP3389411A1 (en) * 2015-12-14 2018-10-24 Nestec S.A. Nutritional composition and infant formula for promoting myelination of the brain
WO2017102720A1 (en) * 2015-12-14 2017-06-22 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
CN105638906A (zh) * 2016-01-11 2016-06-08 东北农业大学 一种满足婴儿的脂质个性化营养需求的婴儿配方奶粉
ES2947592T3 (es) 2016-04-04 2023-08-11 Nutricia Nv Composición para su uso en la reducción o prevención del retraso global del desarrollo de los niños
KR20200003366A (ko) * 2017-05-04 2020-01-09 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 신경발달-촉진 식품 조성물 및 이와 관련된 키트, 시스템 및 방법
CN110945119B (zh) * 2017-07-20 2024-04-05 国立研究开发法人理化学研究所 包含连续上皮的视网膜组织的成熟方法
EP3691621B1 (en) * 2017-09-14 2024-03-27 Kilman Clarke, Lewis Neupanex ®: neuroprotective, neuroregenerational,&neurogenesis supporting supplement combination
WO2019060661A1 (en) * 2017-09-22 2019-03-28 Iowa State University Research Foundation, Inc. PROBIOTIC COMPOSITIONS FOR THE PRODUCTION OF DOPAMINE
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
RU2758128C1 (ru) 2017-12-29 2021-10-26 Крафт Фудс Груп Брэндс Ллк Улучшенная устойчивость к окислению эмульсий типа "масло в воде" при помощи натуральных стабилизаторов

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143234B2 (en) * 1998-07-31 2012-03-27 Massachusetts Institute Of Technology Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function
US20050013884A1 (en) * 2003-07-16 2005-01-20 Rennels M. Scott Compositions and methods for treating heart disease
JP4740866B2 (ja) * 2003-10-24 2011-08-03 ナムローゼ フェンノートシャップ ニュートリシア 乳児向けシンバイオティック組成物
IN2012DN02664A (es) * 2004-10-12 2015-09-11 Fonterra Co Operative Group
AU2012203650B2 (en) * 2005-05-23 2014-09-18 Massachusetts Institute Of Technology Compositions containing PUFA and methods of use thereof
DK1800675T3 (da) * 2005-12-23 2011-09-05 Nutricia Nv Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens
US20130172286A1 (en) * 2010-03-31 2013-07-04 Vegenat, S.A. Functional Food Supplement Intended, In Particular, For Nutrition And For Prevention And Improvement of Neurological Alterations, Neurodegenerative Alterations Or Cognitive Disorders
WO2012125020A1 (en) * 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma

Also Published As

Publication number Publication date
SG11201503682VA (en) 2015-06-29
CN104883909A (zh) 2015-09-02
AU2013372898B2 (en) 2016-12-08
RU2015120263A (ru) 2017-02-16
IN2015DN04207A (es) 2015-10-16
EP2943079A1 (en) 2015-11-18
PE20151771A1 (es) 2015-12-02
US20140199265A1 (en) 2014-07-17
PH12015501504A1 (en) 2015-09-28
HK1214090A1 (zh) 2016-07-22
AU2013372898A1 (en) 2015-05-28
TW201440669A (zh) 2014-11-01
BR112015016358A2 (pt) 2017-07-11
WO2014109862A1 (en) 2014-07-17
CA2912246A1 (en) 2014-07-17
MX2015008585A (es) 2015-09-04

Similar Documents

Publication Publication Date Title
AR094413A1 (es) Composiciones nutricionales conteniendo un componente neurológico y usos de las mismas
CU20190101A7 (es) Imidazopirimidinas diazabicíclicas sustituidas
UY35427A (es) Compuestos y sus usos en la modulación de la hemoglobina
SV2015005066A (es) Compuestos de biaril-amida como inhibidores de cinasa
UY35425A (es) Compuestos y sus usos en la modulación de la hemoglobina
UY35472A (es) Compuestos y sus usos en la modulacion de la hemoglobina
DOP2016000144A (es) Moduladores de tetrahidropiridopirazinas de gpr6
UY35426A (es) Compuestos y sus usos en la modulación de la hemoglobina
CU20170160A7 (es) Derivadosde fenil-tieno(2,3-d)pirimidina- hidroxi-ésteres, un proceso para su preparación y composiciones farmacéuticas que lo contienen
NI201500140A (es) Compuestos y composiciones terapéuticos
UY32923A (es) Compuestos policíclicos como antagonistas del receptor de ácido lisofosfatídico
UY32092A (es) Nuevos compuestos para el tratamiento de trastornos del snc
CR20160033A (es) Inhibidores de autotaxina que comprenden un nucleo ciclico de anillo heteroaromático-bencil-amida
UY33199A (es) 5-alquinil-pirimidinas.
CL2015002222A1 (es) Compuestos de azabencimidazol como inhibidores de isoenzimas pde4 para el tratamiento del snc y otros trastornos.
GT201400222A (es) Agentes para tratar trastornos que implican la modulación de receptores de rianodina
ECSP14008757A (es) Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
UY35628A (es) ?compuestos heteroaromáticos y su uso como ligandos d1 de dopamina?.
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
CL2014003130A1 (es) Compuestos derivados de n-piridinil amidas ciclicas,inhibidores de quinasas pim; composicion farmaceutica que los comprende; combinacion farmaceutica; metodo para tratar enfermedades tales como canceres o un trastorno autoinmune.
BR112015026660A2 (pt) ligas metálicas aperfeiçoadas para dispositivos médicos
NI201600014A (es) Compuestos y composiciones como inhibidores de la mek.
CO7111276A2 (es) Compuestos de 3,5 disustituido-3h imidazo[4,5-b] piridina y 3,5 disustituido - 3h-[1,2,3] triaolo [4,5-b] piridina novedosos como moduladores d proteínas cinasas c-met
UY35711A (es) Bis-amidopiridinas como moduladores de la actividad de iap y sus usos como miméticos de smac
GT201700058A (es) Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos

Legal Events

Date Code Title Description
FB Suspension of granting procedure